Patient Steve Young last year received a cancer immunotherapy as part of a clinical trial at the University College London Hospital. (Photo by Jordan Pettitt/PA Images via Getty Images)
US drugmakers increasingly look abroad for clinical trials as confidence in FDA wavers
When Siren Biotechnology CEO Nicole Paulk learned last month that top FDA official Peter Marks had resigned, she began looking outside the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
